The putative natural PPARγ agonist, 15d-PGJ2, inhibits cellular growth, decreases cellular viability and induces apoptosis in human neuroblastoma cells in vitro [100, 103, 104], although some effects have been demonstrated to be PPARγ-independent [105]. The gene discussed is PPARG; the disease is neuroblastoma.